Delivery Order SPE2DB20D7066-SPE2DB25FC4CQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,265.16 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Atomoxetine HCL 25 mg capsules in quantities of 30. The contract utilizes firm fixed price pricing and carries an ultimate completion date of August 26, 2025. This non-set-aside competitive award will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Atomoxetine is a non-stimulant medication used primarily in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Atomoxetine HCL 60 mg capsules (30-count units) with a ceiling value of $1,096.92. This competitively awarded, firm fixed-price delivery order is non-set-aside and is scheduled for completion by September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 18 mg capsules (30-count) on August 12, 2025, with a ceiling value of $1,569.60 and ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The place of performance is the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atomoxetine HCL 25 mg capsules in quantities of 30 units, with a contract ceiling value of $2,326.72. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded on a non-set-aside, competitive basis. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Atomoxetine HCL 40 mg capsules in quantities of 30 units. This contract represents a non-set-aside, competitively awarded delivery order with firm fixed pricing and a ceiling value of $1,996.53. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Atomoxetine HCL 60 mg capsules (30-count units) with a ceiling value of $1,012.36. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,007.00 to AmerisourceBergen Drug Corp for Atomoxetine HCL 80 mg capsules (30-count units) with a firm fixed price structure. The award, issued on September 19, 2025, is set to be completed by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside contract with no small business restrictions. This delivery order is issued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atomoxetine HCl 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $2,969.40 and a period of performance through April 2025. This contract is not set-aside and was awarded as a firm-fixed price...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Atomoxetine HCL 18 mg capsules (30-count units) with a ceiling value of $1,535.40. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and was awarded without set-aside restrictions through competitive procurement. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,000.60 firm fixed-price contract is for the supply of 4,565,670,077 units of Atomoxetine HCL 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of September 5, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4CQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,505.60 to AmerisourceBergen Drug Corp for the supply of Atomoxetine HCL 40 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atomoxetine is a selective norepinephrine reuptake inhibitor commonly used in the treatment of attention-deficit/hyperactivity disorder (ADHD), indicating this procurement supports the medical supply needs of military and veteran healthcare systems. This delivery order is a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 7/21/25 |